PAR 2.13% 23.0¢ paradigm biopharmaceuticals limited..

Ann: PARADIGM RECEIVES FEEDBACK FROM US FDA ON IND SUBMISSION, page-143

  1. 561 Posts.
    lightbulb Created with Sketch. 62
    yep, we've seen from the trial data so far that a lot of AEs were bruising at injection site, so it's no suprise to hear it is an anticoagulant.
    I doubt that is going to bother anyone that really needs it.

    I was more having a laugh that they made a comment that implied Zydax had shown bruising in humans!
    I'm assuming this stuff isn't approved for human use - otherwise what are we doing here ?

    Perhaps it was just the way I read it smile.png

 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.